DOCSLIB.ORG

Hematopoietic Stem Cells from Induced Pluripotent Stem Cells – Considering the Role of Microrna As a Cell Differentiation Regulator Aline F

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hematopoietic Stem Cells from Induced Pluripotent Stem Cells – Considering the Role of Microrna As a Cell Differentiation Regulator Aline F © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs203018. doi:10.1242/jcs.203018 REVIEW ARTICLE SERIES: STEM CELLS Hematopoietic stem cells from induced pluripotent stem cells – considering the role of microRNA as a cell differentiation regulator Aline F. Ferreira1, George A. Calin2, Virgıniá Picanço-Castro3, Simone Kashima3, Dimas T. Covas3,4 and Fabiola A. de Castro1,* ABSTRACT microRNA (miRNA) expression and epigenetic markers are Although hematopoietic stem cell (HSC) therapy for hematological distinct, indicating that the stem cell differentiation process needs diseases can lead to a good outcome from the clinical point of view, the to be further investigated. limited number of ideal donors, the comorbidity of patients and the Stem cells have proven to be a powerful tool in studies aimed at in vitro increasing number of elderly patients may limit the application of this understanding cell differentiation, and advances in therapy. HSCs can be generated from induced pluripotent stem cells developing cell reprogramming protocols have meant that these (iPSCs), which requires the understanding of the bone marrow and cells can now be induced to differentiate into a number of different in vitro liver niches components and function in vivo. iPSCs have been tissues (Takayama et al., 2010; Teng et al., 2014; Menon extensively applied in several studies involving disease models, drug et al., 2016). iPSC generation has now been achieved by several screening and cellular replacement therapies. However, the somatic methods, including through integration of viruses and episomal reprogramming by transcription factors is a low-efficiency process. plasmids (Meng et al., 2012; Slamecka et al., 2016). Key aspects of Moreover, the reprogramming process is also regulated by microRNAs iPSC production, such as the target tissue, reprogramming factors, (miRNAs), which modulate the expression of the transcription factors method of cell delivery, culture conditions and the biological assays OCT-4 (also known as POU5F1), SOX-2, KLF-4 and MYC, leading to confirm the resulting cell pluripotency potential, are all time- somatic cells to a pluripotent state. In this Review, we present an consuming, arduous and expensive (Maherali and Hochedlinger, overview of the challenges of cell reprogramming protocols with regard 2008). In fact, the technology used to integrate viruses for the to HSC generation from iPSCs, and highlight the potential role of generation of iPSCs represents the main bottleneck for the miRNAs in cell reprogramming and in the differentiation of induced therapeutic application of iPSCs owing to the possibility of viral pluripotent stem cells. vectors being integrated into the genome, which can result in tumorigenesis (Maherali and Hochedlinger, 2008). By contrast, KEY WORDS: HSC, iPSC, miRNA, Cell reprogramming episomal plasmids do not integrate in the genome and typically disappear from iPSCs after 10 to 14 passages (Chou et al., 2011; INTRODUCTION Meng et al., 2012). Stem cells are undifferentiated cells that present an indeterminate Somatic cell reprogramming and iPSC differentiation have the expansion potential to produce progeny through self-renewal or potential to be used in a wide range of therapeutic applications in vitro, differentiation (Sakaki-Yumoto et al., 2013). Furthermore, stem including disease modelling, drug screening and cellular replacement cells have a low-turnover profile, in contrast to their differentiated therapies (Maherali and Hochedlinger, 2008; Giani et al., 2016; progeny (Eckfeldt et al., 2005; Cheng et al., 2000). We focus here Tiyaboonchai et al., 2014); however, the culture conditions of stem on the role of miRNAs in cell reprogramming and induced cells and the particular protocols applied have a great influence on pluripotent stem cell (iPSC) differentiation. The first study to whether the desirable final results are obtained (Fig. 1). demonstrate the formation of iPSCs upon viral-mediated During differentiation, it is expected that stem cells lose the transduction of murine embryonic and adult fibroblasts with expression of the pluripotency-related genes OCT4 and NANOG octamer-binding transcription factor 4 (OCT-4; also known as and begin to express markers associated with differentiation, such as POU5F1), sex-determining region Y-box 2 (SOX-2), v-myc avian GATA4 and GATA6 (Miyamoto et al., 2015). An important issue myelocytomatosis viral oncogene homolog (MYC) and Kruppel- regarding epigenetic markers in stem cells is that the current like factor 4 (KLF-4) was published in 2006 (Takahashi and methods of iPSC cultivation allow the maintenance of the Yamanaka, 2006). Although iPSCs are similar in morphology and epigenetic profile over a long period (Philonenko et al., 2017). pluripotent potential to embryonic stem cells (ESCs), these types of Such epigenetic control may be also mediated by miRNAs (Fig. 1). stem cells are not identical and their gene expression profile, miRNAs are endogenous small non-coding RNA (ncRNAs) consisting of 20 to 22 nucleotides that impair protein expression by binding to mRNAs and interfering with their translation (Ambros, 1Department of Clinical Analysis, Toxicology and Food Science, School of 2004). In this way, miRNAs are involved in fundamental biological Pharmaceutical Sciences, University of São Paulo (USP), Ribeirão Preto, São Paulo 14040-903, Brazil. 2Department of Experimental Therapeutics, MD Anderson processes, including tissue development, cell differentiation, Cancer Center, Houston, TX 77054, USA. 3Center of Cell Therapy, Regional Blood proliferation and apoptosis. Besides all this knowledge with regard Center of Ribeirão Preto, Ribeirão Preto, São Paulo 14051-140, Brazil. 4Department to miRNA function, their role in stem cells differentiation is not that of Internal Medicine, School of Medicine of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, São Paulo 14049-900, Brazil. well understood (Kim et al., 2017). Here, we aim to highlight miRNAs as a relevant regulator of iPSC generation and reprogramming. *Author for correspondence ([email protected]) Protocols for cell differentiation in vitro aim to generate specific A.F.F., 0000-0001-6874-184X; G.A.C., 0000-0002-7427-0578; S.K., 0000-0002- cell types from undifferentiated stem cells by using embryoid bodies 1487-0141; D.T.C., 0000-0002-7364-2595; F.A.d., 0000-0003-3347-5873 as an initial step (Brickman and Serup, 2017). Embryonic bodies are Journal of Cell Science 1 REVIEW Journal of Cell Science (2018) 131, jcs203018. doi:10.1242/jcs.203018 Addition of OCT-4, SOX-2, KLF-4, MYC 5Ј 3Ј 3Ј 5Ј miRNA Fibroblasts regulation iPSC 5Ј 3Ј 3Ј 5Ј Blood cells 3Ј 5Ј 3Ј 5Ј 3Ј 5Ј Somatic cells 3Ј Ј 5 5Ј 3Ј PatientPa en Addition of 5Ј 3Ј miRNAs Fig. 1. General diagram of a somatic cell reprogramming protocol. Somatic cells from patients (fibroblasts or peripheral blood cells), can be reprogrammed by using the transcription factors OCT-4, SOX-2, KLF-4 and MYC, together with a cocktail of miRNAs, or by the addition of miRNAs alone. The resulting iPSCs that have been generated in vitro through somatic cell reprogramming have the potential to be used in a wide range of therapeutic applications and as a research tool (e.g. in vitro disease model). a three-dimensional, multicellular aggregates consisting of the three In cases of autologous HSC transplantation, patients are not germ-layers – endoderm, mesoderm and ectoderm – and are affected by severe GVHD nor by risk of rejection. However, the obtained from spontaneous differentiation of iPSCs when they are disease relapse index is higher in comparison with allogeneic HSC cultured under low-oxygen conditions (Hawkins et al., 2013). transplantation, as no GVHD and graft-versus-leukemia effect Besides the ability to obtain embryonic bodies from iPSCs, (GVL) will occur (i.e. immune response against neoplastic cells) another advantage in using iPSCs for in vitro cell differentiation is and any remaining leukemic cells could then induce the disease that technical manipulations, such as selection of clones or cell relapse. Taken together, all these disadvantages of bone marrow sorting, do not interfere with their ability to differentiate into HSC transplantation highlight the requirement of an alternative hematopoietic tissue (Philonenko et al., 2017). Even if iPSCs require source of HSCs, which aims to reduce the rate of HSC rejection, genetic manipulations (e.g. the introduction of reprogramming disease relapse and bone marrow failure syndromes (graft failure or factors to induce cell pluripotency and self-renewal, such as poor graft function), as well as increasing the possibility of OCT-4, SOX-2 and KLF-4) their properties as iPSCs are obtaining HSCs more easily (van Bekkum and Mikkers, 2012; maintained due to their high genetic and epigenetic stability Masouridi-Levrat et al., 2016). In this regard, iPSCs cells represent a (Philonenko et al., 2017). suitable source that may be used to generate sufficient amounts of Although numerous studies have linked iPSCs or iPSC-differentiated HSCs in vitro with limited immunogenicity (Araki et al., 2013). cells with cell-based therapy, there are, however, still challenges and Despite the success in obtaining in vitro hematopoietic cells from methodology limitations to be overcome. We consider the main iPSCs, the strategy used is laborious and expensive (Yang et al., challenges in generating iPSCs to be: choosing the ideal somatic cell 2017). Furthermore, there is a the lack
Load more

Recommended publications
  • Impaired Production and Increased Apoptosis of Neutrophils in Granulocyte Colony-Stimulating Factor Receptor–Deficient Mice
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Immunity, Vol. 5, 491±501, November, 1996, Copyright 1996 by Cell Press Impaired Production and Increased Apoptosis of Neutrophils in Granulocyte Colony-Stimulating Factor Receptor±Deficient Mice Fulu Liu, Huai Yang Wu, Robin Wesselschmidt, decrease in granulocytic precursors in their bone mar- Tad Kornaga, and Daniel C. Link row (Lieschke et al., 1994). Division of Bone Marrow Transplantation In addition to its effect on granulopoiesis, G-CSF may and Stem Cell Biology also contribute to the regulation of multipotential hema- Department of Medicine topoietic progenitors. The administration of large doses Washington University Medical School of G-CSF is associated with a dramatic increase in the St. Louis, Missouri 63110-1093 levels of hematopoietic stem cells and progenitor cells in the peripheral blood (Bungart et al., 1990; de Haan et al., 1995). In vitro, direct effects of G-CSF on primitive progenitor cells have been demonstrated. G-CSF is able Summary to stimulate the formation of granulocyte/macrophage colonies (CFU-GM) from purified CD34-positiveprogeni- We have generated mice carrying a homozygous null tors (Haylock et al., 1992). Furthermore, like interleu- mutation in the granulocyte colony-stimulating factor kin-6 (IL-6), G-CSF exhibits synergistic activity with IL-3 receptor (G-CSFR) gene. G-CSFR-deficient mice have to support murine multipotential blast cell colony forma- decreased numbers of phenotypically normal circulat- tion in cultures of spleen cells from 5-fluorouracil- ing neutrophils. Hematopoietic progenitors are de- treated mice (Ikebuchi et al., 1988).
    [Show full text]
  • Β-Adrenergic Modulation in Sepsis Etienne De Montmollin, Jerome Aboab, Arnaud Mansart and Djillali Annane
    Available online http://ccforum.com/content/13/5/230 Review Bench-to-bedside review: β-Adrenergic modulation in sepsis Etienne de Montmollin, Jerome Aboab, Arnaud Mansart and Djillali Annane Service de Réanimation Polyvalente de l’hôpital Raymond Poincaré, 104 bd Raymond Poincaré, 92380 Garches, France Corresponding author: Professeur Djillali Annane, [email protected] Published: 23 October 2009 Critical Care 2009, 13:230 (doi:10.1186/cc8026) This article is online at http://ccforum.com/content/13/5/230 © 2009 BioMed Central Ltd Abstract in the intensive care setting [4] – addressing the issue of its Sepsis, despite recent therapeutic progress, still carries unaccep- consequences in sepsis. tably high mortality rates. The adrenergic system, a key modulator of organ function and cardiovascular homeostasis, could be an The present review summarizes current knowledge on the interesting new therapeutic target for septic shock. β-Adrenergic effects of β-adrenergic agonists and antagonists on immune, regulation of the immune function in sepsis is complex and is time cardiac, metabolic and hemostasis functions during sepsis. A dependent. However, β activation as well as β blockade seems 2 1 comprehensive understanding of this complex regulation to downregulate proinflammatory response by modulating the β system will enable the clinician to better apprehend the cytokine production profile. 1 blockade improves cardiovascular homeostasis in septic animals, by lowering myocardial oxygen impact of β-stimulants and β-blockers in septic patients. consumption without altering organ perfusion, and perhaps by restoring normal cardiovascular variability. β-Blockers could also β-Adrenergic receptor and signaling cascade be of interest in the systemic catabolic response to sepsis, as they The β-adrenergic receptor is a G-protein-coupled seven- oppose epinephrine which is known to promote hyperglycemia, transmembrane domain receptor.
    [Show full text]
  • Monocyte Alterations in Rheumatoid Arthritis Are Dominated by Preterm
    Ann Rheum Dis: first published as 10.1136/annrheumdis-2017-211649 on 30 November 2017. Downloaded from Basic and translational research EXTENDED REPORT Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint Biljana Smiljanovic,1 Anna Radzikowska,2 Ewa Kuca-Warnawin,2 Weronika Kurowska,2 Joachim R Grün,3 Bruno Stuhlmüller,1 Marc Bonin,1 Ursula Schulte-Wrede,3 Till Sörensen,1 Chieko Kyogoku,3 Anne Bruns,1 Sandra Hermann,1 Sarah Ohrndorf,1 Karlfried Aupperle,1 Marina Backhaus,1 Gerd R Burmester,1 Andreas Radbruch,3 Andreas Grützkau,3 Wlodzimierz Maslinski,2 Thomas Häupl1 Handling editor Tore K Kvien ABSTRACT of life.1 2 Infiltration of monocytes along with T and Objective Rheumatoid arthritis (RA) accompanies B cells into the joint and production of inflamma- ► Additional material is published online only. To view infiltration and activation of monocytes in inflamed tory mediators characterise the immunopathology please visit the journal online joints. We investigated dominant alterations of RA of this disease. The influence of the monocytic (http:// dx. doi. org/ 10. 1136/ monocytes in bone marrow (BM), blood and inflamed lineage in shaping the immune response is substan- annrheumdis- 2017- 211649). joints. tial and interferes with both the innate and adap- Methods CD14+ cells from BM and peripheral blood tive arm of immunity. Thus, it is not surprising 1Department of Rheumatology and Clinical Immunology, (PB) of patients with RA and osteoarthritis (OA) were that controlling inflammation in disease-modifying Charité Universitätsmedizin, profiled with GeneChip microarrays.D etailed functional antirheumatic drug (DMARD) non-responders Berlin, Germany analysis was performed with reference transcriptomes may be achieved when targeting monocyte-derived 2 Department of Pathophysiology of BM precursors, monocyte blood subsets, monocyte cytokines, tumour necrosis factor (TNF), inter- and Immunology, National activation and mobilisation.
    [Show full text]
  • Pre and Postnatal Hematopoiesis
    Pre_ and postnatal hematopoiesis Assoc. Prof. Sinan Özkavukcu Department of Histology and Embryology Lab Director, Center for Assisted Reproduction, Dep. of Obstetrics and Gynecology [email protected] 3 8 6 40 8 28 18 E Hemopoiesis (Hematopoiesis) • It is carried out in hematopoietic organs. • Erythropoiesis • Leukopoiesis • Thrombopoiesis ■Erythrocytes, platelets and granulocytes (neutrophils, eosinophils, basophil leukocytes) of blood cells are produced in myeloreticular tissue (red bone marrow). ■Agranulocytes (lymphocytes and monocytes); they are made both in the red bone marrow and in the lymphoreticular tissues (lymphoid organs). Ensuring continuity • The circulating blood cells have certain lifetimes. The cells are constantly destroyed and renewed. Therefore, a continuous production dynamics is needed. Blood product Life span Red blood cells 120 days Fetal red blood cells 90 days Platelets 7-12 days Transfused platelets 36 hours 8-12 hours in circulation Neutrophils 4-5 days in tissue Prenatal hematopoiesis • Yolk sac Stage 3rd Week Hemangioblast formation Prenatal Hemopoez Mesoblastic phase (2nd week-mesoderm of the yolk sac) Hepatosplenothymic phase Liver (6th week) Spleen (8th week) Thymus (8th week) Medullalymphatic phase (3-5th month) Temporary blood islets of the yolk sac • In the 3rd week of embryological development, mesodermal cells in the yolk sac wall are differentiated into hemangioblast cells. • These cells are the precursors of both blood cells and endothelial cells that will form the vascular system. • Blood precursors formed in this region are temporary. • The main hematopoietic stem cells develop from the mesoderm surrounding the aorta, called the aorta-gonad-mesonephros region (AGM), next to the developing mesonephric kidney. • These cells colonize the liver and form the main fetal hematopoietic organ (2-7th month of pregnancy) • Cells in the liver then settle into the bone marrow, and from the 7th month of pregnancy, the bone marrow becomes the final production center 1.
    [Show full text]
  • A Double-Edged Sword of Immuno-Microenvironment in Cardiac Homeostasis and Injury Repair
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans REVIEW ARTICLE OPEN A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair Kang Sun1, Yi-yuan Li2 and Jin Jin 1,3 The response of immune cells in cardiac injury is divided into three continuous phases: inflammation, proliferation and maturation. The kinetics of the inflammatory and proliferation phases directly influence the tissue repair. In cardiac homeostasis, cardiac tissue resident macrophages (cTMs) phagocytose bacteria and apoptotic cells. Meanwhile, NK cells prevent the maturation and transport of inflammatory cells. After cardiac injury, cTMs phagocytose the dead cardiomyocytes (CMs), regulate the proliferation and angiogenesis of cardiac progenitor cells. NK cells prevent the cardiac fibrosis, and promote vascularization and angiogenesis. Type 1 macrophages trigger the cardioprotective responses and promote tissue fibrosis in the early stage. Reversely, type 2 macrophages promote cardiac remodeling and angiogenesis in the late stage. Circulating macrophages and neutrophils firstly lead to chronic inflammation by secreting proinflammatory cytokines, and then release anti-inflammatory cytokines and growth factors, which regulate cardiac remodeling. In this process, dendritic cells (DCs) mediate the regulation of monocyte and macrophage recruitment. Recruited eosinophils and Mast cells (MCs) release some mediators which contribute to coronary vasoconstriction, leukocyte recruitment, formation of new blood vessels, scar formation. In adaptive immunity, effector T cells, especially Th17 cells, lead to the pathogenesis of cardiac fibrosis, including the distal fibrosis and scar formation. CMs protectors, Treg cells, inhibit reduce the inflammatory response, then directly trigger the regeneration of local progenitor cell via IL-10. B cells reduce myocardial injury by fl 1234567890();,: preserving cardiac function during the resolution of in ammation.
    [Show full text]
  • Immunology Targeted Therapy
    Published OnlineFirst August 20, 2015; DOI: 10.1158/2159-8290.CD-RW2015-156 rEsEarch WATCH targeted therapy Major finding: Small-molecule blockade Mechanism: DEL-22379 inhibits ERK impact: Regulatory protein–protein of ERK dimerization delays tumorigenesis extranuclear activity and is not affected interactions represent potential driven by oncogenic RAS–ERK signaling. by drug-resistance mechanisms. therapeutic targets. inhibition of ErK dimErization impairs RAS–ErK-drivEn tumorigEnEsis Constitutive activation of the RAS–ERK pathway occurs of phosphoprotein enriched in astrocytes 15 (PEA15), which in nearly 50% of human cancers. Although several phar- retains ERK in the cytoplasm, correlated with levels of ERK macologic strategies to block this pathway have yielded dimerization and DEL-22379 sensitivity in BRAF-mutant positive results, long-lasting efficacy has been hampered by cells, supporting the idea that the antitumor activity of acquired resistance mutations that reactivate ERK signaling. DEL-22379 is dependent on ERK dimerization. Consistent As an alternative approach, Herrero and colleagues sought with this finding, DEL-22379 was ineffective in a RAS-driven to inhibit ERK dimerization, which specifically regulates the melanoma model in zebrafish, in which ERK does not dimer- extranuclear function of ERK and has been implicated in ize. Importantly, melanoma cells with NRAS overexpression tumorigenesis. Screening of small-molecule libraries identi- or MEK1 mutations remained sensitive to DEL-22379 treat- fied DEL-22379, which successfully blocked ERK dimeriza- ment, indicating that the antitumor activity of DEL-22379 is tion without affecting its phosphorylation; correspondingly, not affected by drug-resistance mechanisms associated with ERK cytoplasmic activity was significantly reduced, whereas existing inhibitors of the RAS–ERK pathway.
    [Show full text]
  • THE ROLE of DMSO in the REGULATION of IMMUNE RESPONSES by DENDRITIC CELLS ELAINE LAI MIN CHERN (B.Sc (Hons), NUS)
    THE ROLE OF DMSO IN THE REGULATION OF IMMUNE RESPONSES BY DENDRITIC CELLS ELAINE LAI MIN CHERN (B.Sc (Hons), NUS) A THESIS SUBMITTED FOR THE DEGREE OF MASTER OF SCIENCE DEPARTMENT OF MICROBIOLOGY NATIONAL UNIVERSITY OF SINGPAPORE 2010 ACKNOWLEDGEMENTS I would like to express my heartfelt gratitude to Assoc. Prof. Lu Jinhua for his dedicated supervision and encouragement throughout the project. His advice and concerns beyond academic and research were and will be always treasured. I would also like to take this opportunity to thank my friends and colleagues in the laboratory for their help, support and friendship during the course of my research. Special thanks to Boon King for the primers used in real time PCR. My gratitude also goes to the staffs at the National University Hospital Blood Bank and Blood Donation Centre for their help in buffy coat preparations. Lastly, I am ever grateful to my parents and husband, Jack Sheng for their care and support given unconditionally throughout my Master studies. I TABLE OF CONTENTS Acknowledgements I Table of Contents II Summary VII List of Tables VIII List of Figures IX List of Abbreviations XI Chapter 1 Introduction 1.1 The Immune System 1 1.2 Innate Immunity 1.2.1 Overview of Innate Immunity 4 1.2.2 Myeloid Cells Form a Major Arm of Innate Immunity 5 1.2.2.1 Monocytes 6 1.2.2.2 Monocytes Differentiation 8 1.2.2.3 Macrophages 10 1.2.2.4 Dendritic Cells 17 1.2.2.5 Heterogeneity of Dendritic Cells Subsets 18 1.2.2.6 DC Maturation and Migration 23 1.2.2.7 DCs in antigen uptake, processing and presentation
    [Show full text]
  • A Novel Macrophage Subtype Directs Hematopoietic Stem Cell Homing and Retention
    79 Editorial Commentary Page 1 of 4 A novel macrophage subtype directs hematopoietic stem cell homing and retention Marcin Wysoczynski1, Joseph B. Moore IV1, Shizuka Uchida1,2 1Institute of Molecular Cardiology, Department of Medicine, 2Cardiovascular Innovation Institute, University of Louisville, Louisville, KY, USA Correspondence to: Shizuka Uchida. Associate Professor of Medicine, Cardiovascular Innovation Institute, University of Louisville, Louisville, KY 40202, USA. Email: [email protected]; [email protected]. Provenance: This is an invited article commissioned by the Section Editor Liuhua Zhou, MD (Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China). Comment on: Li D, Xue W, Li M, et al. VCAM-1+ macrophages guide the homing of HSPCs to a vascular niche. Nature 2018;564:119-24. Submitted Mar 19, 2019. Accepted for publication Mar 31, 2019. doi: 10.21037/atm.2019.04.11 View this article at: http://dx.doi.org/10.21037/atm.2019.04.11 Early embryonic hematopoiesis in vertebrates proceeds in functions to actively recruit stem cells and maintain their two consecutive waves (Figure 1). The first wave, defined as plasticity throughout adulthood (2,4,5). While much is primitive hematopoiesis, takes place in the extraembryonic known regarding these processes, many of the factors which yolk sac and generates transitory hematopoietic cell compose the HSC milieu, as well as the precise signaling populations consisting of primitive erythrocytes. During events that direct HSC migration and preserve stemness, this first wave, small number of myeloid cells (e.g., primitive remain undefined. There is growing evidence that during monocytes/macrophages and megakaryocytes) are also primitive hematopoiesis in the developing embryo that generated.
    [Show full text]
  • 'Neutropenia' in Black West Indians
    Postgrad Med J: first published as 10.1136/pgmj.63.738.257 on 1 April 1987. Downloaded from Postgraduate Medical Journal (1987) 63, 257-261 'Neutropenia' in Black West Indians A.V. Zezulka, J.S. Gill and D.G. Beevers University Department ofMedicine, Dudley Road Hospital, Birmingham B18 8QH, UK. Summary: A prospective case control study of routine haematological parameters was conducted in 294 healthy Black and White age/sex-matched subjects. The most important finding relevant to clinical practice was a reduction of total white cell count in Blacks due mainly to reduced neutrophil numbers. Twenty-one percent ofsickle negative Blacks had white cell counts below the lowest value seen in Whites. The haemoglobin concentration, erythrocyte mean cell volume and monocyte count were also significantly lower amongst Blacks though lymphocyte counts were higher. The racial differences in haemoglobin and white count were not accounted for by differences in smoking and drinking habits. They were also found when Blacks with sickle cell trait were compared to age/sex-matched Whites and in others taking the oral contraceptive pill. Awareness of racial group should aid interpretation of routine tests and avoid unnecessary investigation of normal 'neutropenic' Blacks. Introduction Awareness ofracial differences in health and disease is taken for routine full blood count and indices, dif- important to clinical practice in both the developed ferential white cell and platelet counts. Full blood copyright. and emerging nations. Medical contact with different count was measured on a potassium EDTA sample by ethnic groups is particularly frequent in British inner a standard automated method using the Coulter city areas.
    [Show full text]
  • Hematopoiesis
    UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY Department of Histology, Cytology and Embryology Hematopoiesis PhD, Teacher of Department of Histology, Cytology and Embryology Skotarenko Tetiana Plan of lecture 1. General characteristics of the organs of hematopoiesis. 2. Embryonic hematopoiesis. 3. Postembryonic hematopoiesis. 4. The modern theory of hematopoiesis. 5. Stem cells. 6. Characterization of cells of all classes of hematopoiesis. 2 Hematopoiesis is development of the blood cells. Mature blood cells have a relatively short life span, and the population must be replaced by the progeny of stem cells produced in the hematopoietic organs. Types of hematopoiesis ► embryonic (prenatal) hematopoiesis which occurs in embryonic life and results in development of a blood as tissue, ► postembryonic (postnatal) hematopoiesis which represents process of physiological regeneration of a blood. Development of erythrocytes name an erythropoiesis, of granulocytes – granulopoiesis, of thrombocytes - thrombopoiesis, of monocytes - monopoiesis, of lymphocytes and immunocytes - lympho- and immunopoiesis. ► In the prenatal period the hematopoiesis serially occurs in several developing organs. ► After birth the hematopoiesis occurs in the bone marrow of a skull, ribs, sternum, pelvic bones, epiphysises of the lengthy bones. Prenatal hematopoiesis 1. The primary (megaloblastic) stage. During 2-3 weeks of development in the wall of the yolk sac the clumps of mesenchymal cells - blood islands - are formed. Prenatal hematopoiesis 1. The primary (megaloblastic) stage Cells on periphery of each island form the endothelium of primary blood vessels. The cells of the central part of an island form the first blood cells - primary erythroblasts - the large cells containing a nucleus and embryonic Hb. Prenatal hematopoiesis 1. The primary (megaloblastic) stage ► Leucocytes and thrombocytes at this stage are not present.
    [Show full text]
  • Factor XIII-A in Diseases: Role Beyond Blood Coagulation
    International Journal of Molecular Sciences Review Factor XIII-A in Diseases: Role Beyond Blood Coagulation Katalin Dull, Fruzsina Fazekas and Dániel Tör˝ocsik* Department of Dermatology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, H4032 Debrecen, Hungary; [email protected] (K.D.); [email protected] (F.F.) * Correspondence: [email protected]; Tel.: +36-52-255-602 Abstract: Multidisciplinary research from the last few decades has revealed that Factor XIII subunit A (FXIII-A) is not only involved in blood coagulation, but may have roles in various diseases. Here, we aim to summarize data from studies involving patients with mutations in the F13A1 gene, performed in FXIII-A knock-out mice models, clinical and histological studies assessing correlations between diseases severity and FXIII-A levels, as well as from in vitro experiments. By providing a complex overview on its possible role in wound healing, chronic inflammatory bowel diseases, athe-rosclerosis, rheumatoid arthritis, chronic inflammatory lung diseases, chronic rhinosinusitis, solid tumors, hematological malignancies, and obesity, we also demonstrate how the field evolved from using FXIII-A as a marker to accept and understand its active role in inflammatory and malignant diseases. Keywords: Factor XIII subunit A; chronic inflammatory diseases; malignancies 1. Introduction In the plasma, Factor XIII is present as a heterotetramer (FXIII-A2B2), consisting of two A subunits (FXIII-A) with catalytic activity and two B subunits (FXIII-B) that inhibit FXIII- A by binding to it. During the coagulation cascade, thrombin cleaves off the activation peptide from A subunit, the B subunit dissociates in a Ca2+-dependent manner, and FXIII-A Citation: Dull, K.; Fazekas, F.; becomes an active transglutaminase cross-linking fibrin strands, accounting for its role in Tör˝ocsik,D.
    [Show full text]
  • Basics of Bone Marrow
    E Pluribus Unum Bone Marrow Jack Goldberg MD Clinical Professor of Medicine University of Pennsylvania Origins of Leukemia Lymphopoiesis Monocytopoiesis stem Pluripotent stem cell Granulopoiesis Sites of Hematopoiesis (Hemocytoblast) cell Erythropoiesis Thrombopoiesis • Yolk sac Pro-erythroblast • Liver and spleen Lymphoblast Monoblast Myeloblast Megakaryoblast Basophilic Pro-Myelocyte erythroblast • Bone marrow – Gradual replacement of Myelocyte Polychromatic erythroblast active (red) marrow by tissue inactive (fatty) Orthocromatic Metamylelocyte erythroblast – Expansion can occur during increased need for Band granulocyte Reticulocyte Megakaryocyte cell production Lymphocyte RBC Platelets Monocyte Granulocyte BLOOD IS MADE IN THE BONE MARROW • Axial skeleton • Inner spongy bone • Bone marrow is in the holes • Bone marrow is a highly organized / regulated organ DMM00_B3.ppt 1 BONE MARROW: THE SOURCE OF BLOOD AND OUR Introduction IMMUNE SYSTEM • All blood cells arise from • Limited Life span of : “mother” (stem) cells – Self renewing • Granulocytes – Safe from harm • Erythrocytes – Pluripotent • Platelets • Blood production is highly regulated • Lymphocytes – Messages from the body (e.g. erythropoietin from kidney) – Microenvironments produce specific cells Normal bone • Cytokines (SCF, IL3) marrow • Growth factors (G-CSF) BAS03_20.ppt Regulation of Haemopoiesis Introduction • Stem cells • Self renewal • Plasticity Controlled cell Controlled cell production • Progenitor cells death • Developmentally-restricted cells • Mature cells • There
    [Show full text]